Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 6 results.
User Information
Export Records
  1. 1.   Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects
  2. Moaddel, Ruin; Shardell, Michelle; Khadeer, Mohammed; Lovett, Jacqueline; Kadriu, Bashkim; Ravichandran, Ravi; Morris, Patrick J; Yuan, Peixiong; Thomas, Craig J; Gould, Todd D; Ferrucci, Luigi; Zarate, Carlos A
  3. Psychopharmacology. 2018, Oct; 235(10): 3017-3030.
  1. 2.   Targeting of Bone-Derived Insulin-Like Growth Factor-II by a Human Neutralizing Antibody Suppresses the Growth of Prostate Cancer Cells in a Human Bone Environment
  2. Kimura, T.; Kuwata, T.; Ashimine, S.; Yamazaki, M.; Yamauchi, C.; Nagai, K.; Ikehara, A.; Feng, Y.; Dimitrov, D. S.; Saito, S.; Ochiai, A.
  3. Clinical Cancer Research. 2010, Jan; 16(1): 121-129.
  1. 3.   Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib
  2. Gardner, E. R.; Burger, H.; van Schaik, R. H.; van Oosterom, A. T.; de Bruijn, E. A.; Guetens, G.; Prenen, H.; de Jong, F. A.; Baker, S. D.; Bates, S. E.; Figg, W. D.; Verweij, J.; Sparreboom, A.; Nooter, K.
  3. Clinical Pharmacology & Therapeutics. 2006, Aug; 80(2): 192-201.
  1. 4.   A high-throughput cell-based assay for inhibitors of ABCG2 activity
  2. Henrich, C. J.; Bokesch, H. R.; Dean, M.; Bates, S. E.; Robey, R. W.; Goncharova, E. I.; Wilson, J. A.; McMahon, J. B.
  3. Journal of Biomolecular Screening. 2006, Mar; 11(2): 176-183.
  1. 5.   Crystal structures of a high-affinity macrocyclic peptide mimetic in complex with the Grb2 SH2 domain
  2. Phan, J.; Shi, Z. D.; Burke, T. R.; Waugh, D. S.
  3. Journal of Molecular Biology. 2005, OCT 14; 353(1): 104-115.
  1. 6.   Introduction and overview. Perinatal carcinogenesis: growing a node for epidemiology, risk management, and animal studies
  2. Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2004, SEP 1; 199(2): 85-90.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel